Conference for Early Stage HIV/AIDS Vaccine Researchers (R13)
The objectives of the meeting supported by this FOA are to provide these early stage HIV/AIDS vaccine researchers with guidance on conducting preclinical research to inform HIV vaccine strategies for clinical trials and developing skills related to networking, work-life balance, grantsmanship, and goal/milestone-oriented projects. Conference topics should include, but not be limited to: critical aspects of human vaccine development, including statistical considerations, host genetics and others; methods to translate the results of NHP challenge studies to clinical trials in humans; and methods to develop milestone-driven projects.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
More News: AIDS Vaccine | Clinical Trials | Conferences | Contracts | Funding | Genetics | Grants | HIV AIDS | Research | Statistics | Study | Vaccines | Workshops